ARTICLE | Clinical News
Lutathera regulatory update
December 27, 2016 5:13 PM UTC
FDA issued a complete response letter to Advanced Accelerator for Lutathera to treat gastroenteropancreatic neuroendocrine tumors. The company said in late November that FDA issued a "discipline revie...
BCIQ Target Profiles